Can Food Timing Reduce Your Diabetes Risk?
Launched by BRIGHAM AND WOMEN'S HOSPITAL · May 11, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Can Food Timing Reduce Your Diabetes Risk?", is looking to find out if when we eat our meals can affect our overall health, especially in relation to metabolic conditions like diabetes. The study will involve healthy participants who will spend time in a research facility, where they will eat specific test meals and have their blood drawn regularly to monitor their health.
To participate, individuals should be between the ages of 65 and 74 and have a body mass index (BMI) between 18.5 and 29.9, which means they should not be underweight or obese. Participants should not have any serious medical or mental health issues, and they should not smoke or have any drug or alcohol dependencies. If you join this trial, you can expect to spend some time in a controlled setting, eating provided meals and undergoing health assessments to help researchers understand the impact of meal timing on health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy with no acute or chronic medical and psychiatric disorders
- • BMI: 18.5-29.9 kg/m2
- Exclusion Criteria:
- • Smokers, current tobacco or e-cigarette use
- • Drug or alcohol dependency
- • Pregnant
About Brigham And Women's Hospital
Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Frank Scheer, PhD
Principal Investigator
Brigham and Women's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported